glp 1 drugs in development What is the pipeline for future medications for obesity? The GLP-1 Revolution: From Diabetes

J Biol Chem 287(6):42114221 Moll S, Varga EA (2015) Homocysteine and MTHFR mutations

Specifically, upon GDH1 deletion, the elevated levels of -ketoglutarate, and not those of NADH, resulted in the observed telomeric silencing defects [40]

Among the groups of people with conditions who should consult a doctor before choosing L-carnitine supplementation are those with renal, hepatic or cardiovascular disorders, among others

Wellness and supplement ingredients The surge in searches for supplements and ingestible ingredients like exosomes, colostrum, Himalayan salt, NMN and cayenne pepper suggests a growing interest in both unconventional and natural health solutions

Certain probiotics can produce short-chain fatty acids (SCFAs), such as butyrate, through the fermentation of soluble fibre

A Potential New Approach to Addiction Treatment Millions of Americans already use GLP-1 medications, and that number continues to grow